Liberate Medical

Liberate Medical is a private medical device company targeting a critical unmet need in intensive care: respiratory muscle atrophy in mechanically ventilated patients. Its core innovation is the VentFree device, which uses proprietary, non-invasive electrical stimulation synchronized with exhalation to maintain expiratory muscle activity from the first day of ventilation. With CE Mark in Europe and an FDA Emergency Use Authorization in the US, the company is positioned to address a high-cost complication associated with prolonged ICU stays, backed by promising pilot clinical data showing reductions in ventilation duration and ICU length of stay.

Proprietary non-invasive neuromuscular electrical stimulation (NMES) synchronized with mechanical ventilator exhalation to contract abdominal expiratory muscles.

The direct competitive landscape for synchronized abdominal NMES in ventilation is nascent, with few commercialized devices. Indirect competition includes general physiotherapy techniques and other ventilator weaning protocols. Liberate's first-mover advantage and focused clinical data are key differentiators.